Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 6th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | NOVARTIS AG | $123.73 | 0.64% | 1.50% | 4.34% | 19.66% | 24.88% | 12.54% | 46.44% | 42.20% | 19.87% | $124.83 | $96.06 | 0.88% | 28.80% | 0.35 | 1,667,000 | 39.73% |
| JNJ | JOHNSON & JOHNSON | $157.69 | 0.90% | 1.08% | 0.79% | 6.05% | 11.00% | 5.53% | -11.58% | 10.76% | 58.43% | $169.99 | $140.68 | 7.24% | 12.09% | 0.26 | 6,733,000 | 9.52% |
| GRFS | GRIFOLS SA | $9.75 | 3.83% | 7.38% | 8.09% | 49.54% | 33.74% | 9.43% | -11.68% | -47.47% | -37.66% | $9.96 | $6.19 | 2.11% | 57.51% | 0.75 | 1,508,000 | -53.38% |
| GILD | GILEAD SCIENCES INC | $114.54 | 1.15% | 2.50% | 4.04% | 12.96% | 27.44% | 66.60% | 82.80% | 50.08% | 0.70% | $119.96 | $69.91 | 4.52% | 63.84% | 0.43 | 6,097,000 | 16.53% |
| GSK | GSK PLC | $39.58 | 1.38% | 3.67% | -4.16% | 17.80% | 19.61% | 2.65% | -25.09% | -20.66% | -25.41% | $44.67 | $31.72 | 11.39% | 24.80% | 0.38 | 6,087,000 | 67.96% |
| AMGN | AMGEN INC | $300.37 | 1.30% | 0.71% | 2.37% | 6.74% | 14.54% | -6.62% | 21.22% | 20.61% | 94.92% | $346.85 | $253.30 | 13.40% | 18.58% | 0.48 | 1,926,000 | -8.20% |
| BMY | BRISTOL MYERS SQUIBB CO | $48.52 | 1.80% | 3.41% | -2.90% | -3.84% | -13.09% | 18.00% | -35.79% | -15.51% | -29.96% | $63.33 | $39.93 | 23.39% | 21.53% | 0.34 | 14,732,000 | 23.29% |
| AZN | ASTRAZENECA PLC | $71.81 | 1.40% | 3.40% | -2.74% | 10.70% | 7.16% | -7.64% | 7.60% | 33.58% | 116.13% | $87.68 | $61.24 | 18.10% | 17.26% | 0.44 | 4,047,000 | 10.39% |
| ABBV | ABBVIE INC | $195.00 | 2.30% | 3.02% | 2.90% | 11.94% | 11.32% | 15.97% | 27.26% | 101.38% | 181.67% | $218.66 | $163.81 | 10.82% | 19.04% | 0.40 | 6,049,000 | 8.13% |
| PFE | PFIZER INC | $25.78 | 0.86% | 1.58% | 6.09% | 19.41% | -3.52% | -9.07% | -51.26% | -23.80% | -24.97% | $31.54 | $20.92 | 18.26% | 23.26% | 0.42 | 39,481,000 | 2.97% |
| SNY | SANOFI | $49.34 | 1.04% | 2.15% | -1.08% | -0.64% | 1.25% | -3.31% | -1.89% | -1.87% | -4.18% | $60.12 | $45.80 | 17.92% | 7.73% | 0.35 | 2,219,000 | -3.90% |
| LLY | ELI LILLY & CO | $790.65 | 0.47% | 1.28% | -2.05% | 9.67% | -1.16% | -15.87% | 138.82% | 383.99% | 795.51% | $972.53 | $677.09 | 18.70% | 16.77% | 0.60 | 3,131,000 | 15.83% |
| SCLX | SCILEX HOLDING CO | $6.49 | 1.41% | 2.04% | 7.63% | -25.80% | -59.21% | -89.98% | -98.19% | N/A | N/A | $73.50 | $3.60 | 91.17% | 80.28% | 0.33 | 66,400 | -19.02% |
| BIIB | BIOGEN INC | $135.33 | 1.74% | 1.85% | -0.12% | 19.36% | -9.06% | -41.86% | -37.13% | -51.47% | -65.14% | $238.00 | $110.04 | 43.14% | 22.99% | 0.77 | 992,000 | -35.08% |
| MRK | MERCK & CO INC | $84.02 | 0.37% | 3.82% | 3.28% | 8.34% | -15.35% | -34.00% | -10.90% | 9.50% | 44.99% | $129.93 | $73.31 | 35.33% | 14.61% | 0.31 | 14,729,000 | -19.93% |
| OGN | ORGANON & CO | $10.02 | 1.11% | 0.60% | -0.20% | -12.34% | -36.78% | -49.70% | -69.36% | N/A | N/A | $23.10 | $8.01 | 56.62% | 25.09% | 0.80 | 3,810,000 | 4.67% |
| AMRN | AMARIN CORP PLC | $17.32 | -0.06% | 3.53% | 35.10% | 91.81% | 56.94% | 14.17% | -39.44% | -87.11% | -64.07% | $17.49 | $7.08 | 0.97% | 144.63% | 1.12 | 96,000 | -25.58% |
| MIRA | MIRA PHARMACEUTICALS INC | $1.20 | 6.19% | 0.00% | -4.00% | 42.18% | -4.76% | 114.67% | N/A | N/A | N/A | $5.01 | $0.58 | 76.05% | 106.90% | 1.72 | 1,976,000 | 25.86% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.